Trademarkia Logo

Canada

C$
PENGUIN O DESIGN
ABANDONED SECTION 36

on 10 Sept 2019

Last Applicant/ Owned by

MAPIX S.À.R.L

32 boulevard d'Avranches L-1160 Luxembourg

LU

Serial Number

1863551 filed on 19th Oct 2017

Correspondent Address

SMART & BIGGAR LP

SUITE 1000, 55 METCALFE STREETP.O. BOX 2999, STATION DOttawa

ONTARIO

CA

K1P5Y6

PENGUIN O DESIGN

Trademark usage description

pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or Read More

Vienna Information


3 . 7 . 8

PenguinsPingouins

27 . 3 . 1

Letters or numerals representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an objectLettres ou chiffres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet

27 . 3 . 3

Letters or numerals representing an animal or a part of an animal's bodyLettres ou chiffres représentant un animal ou une partie du corps d'un animal

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 21

One letterUne lettre

29 . 1 . 4

BlueBleu

Classification Information


Class [005]
Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary use, food for babies; dietary supplements for humans and animals; disinfectants; drugs for the prevention and treatment of inflammation and inflammatory diseases, respiratory and infectious diseases, immunological, bacterial, viral and fungal infections, herpes infections, including herpes type I and II, genital herpes, labial herpes and other diseases caused by herpes viruses (varicella, infectious mononucleosis); drugs for prevention and treatment of enterovirus, rotavirus, coronavirus, adenoviral diseases; drugs for prevention and treatment of diseases caused by tick-borne encephalitis virus, calicivirus, respiratory viruses; antibody- based drugs; antibody-based drugs, including drugs for the prevention and treatment of inflammation and inflammatory diseases, respiratory and infectious diseases, immunological, bacterial, viral and fungal infections, herpes infections, including herpes type I and II, genital herpes, labial herpes and other diseases caused by herpes viruses (varicella, infectious mononucleosis); antibody-based drugs for the prevention and treatment of enterovirus, rotavirus, coronaviruses, adenoviral diseases; antibody- based drugs to prevent and treat diseases caused by tick-borne encephalitis virus, calicivirus, espiratory viruses; drugs for the treatment of AIDS/HIV infection; antibody-based drugs for the treatment of AIDS/HIV infection; drugs for the treatment of viral hepatitis; antibody-based drugs for the treatment of viral hepatitis; drugs for the treatment of influenza; antibody-based drugs for the treatment of influenza; disinfectants for hygiene purposes, including disinfectants fighting microorganisms which cause infectious disease in man; immunomodulators; anti-mutagenic drugs.


Classification kind code

11

Mark Details


Serial Number

1863551

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 6
on 10th Sept 2019
Abandoned - Section 36
Submitted for opposition 14
on 18th Jun 2019
Default Notice Sent
Submitted for opposition 87
on 1st Apr 2019
Rep for Service Changed
Submitted for opposition 48
on 1st Apr 2019
Agent Changed
Submitted for opposition 22
on 26th Nov 2018
Search Recorded
Submitted for opposition 20
on 26th Nov 2018
Examiner's First Report
Submitted for opposition 31
on 23rd Oct 2017
Formalized
Submitted for opposition 1
on 20th Oct 2017
Created
Submitted for opposition 30
on 19th Oct 2017
Filed